Belite Bio files Japan NDA for tinlarebant in Stargardt disease type 1Sep 8Regulatory milestoneBelite Bio, Inctinlarebant
Belite Bio posts Q2 2026 results as FDA reviews tinlarebant NDA under priority reviewAug 12Regulatory milestoneBelite Bio, Inctinlarebant
Sign inSign in